Health
Moderna Receives Additional $472 Million to Develop Coronavirus Vaccine – The Motley Fool
Moderna’s contract with the government has been amended to include extra funding for a 30,000-patient phase 3 study.
Moderna’s (NASDAQ:MRNA) lucrative relationship with the U.S. government took another big step forward on Sunday. The Biomedical Advanced Research and Development Authority (BARDA) amended its contract with the clinical-stage biotechnology company for an additional commitment of up to $472 million.
In April, BARDA agreed to a commitment of up to $483 million to support the advancement of Moderna’s coronavirus vaccine candidate, mRNA-1273, from phase 1 trials through FDA licensure. The total valu…
-
Noosa News12 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General23 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News22 hours agoE-Scooter accident | Noosa Today
-
General21 hours agoOutback Farm stars finish first barley harvest at Central Australian farm